The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Sickle Cell Disease Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2019 | SCD: Assessing bleeding severity in thrombocytopenic patients
Bart Biemond, MD, PhD, Academic Medical Centre, Amsterdam, Netherlands, discusses the assessment of bleeding severity in thrombocytopenic, sickle cell anemia patients at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.
